News for hackers. Stuff that matters.
Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @04:55AM (#16828148)
> The 'ideal' drug from a business point of view not only not cures the patient long term...

There is another one. Vaccines. Or any preventive medicines that does not actually require people to be sick.

You just need to inject massive amount of fear of diseases (Statistics is your friend here) into the populace to create a nice, ever increasing demand of your produce...

Re:Goldman Sachs questions whether curing patients is a sust... by ta76567656 on Friday April 13, 2018 @06:15AM (#16828521)
I rather enjoy never having gotten smallpox or polio.
Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @07:31AM (#16828959)
What part of my comment are you responding to?
Re:Goldman Sachs questions whether curing patients is a sust... by bonzini on Friday April 13, 2018 @02:58PM (#16832940)
The part about fear of diseases, for example. We've always feared diseases, and the fear was due to having seen babies or young people die of diseases that have now almost disappeared, such as measles.

People that think they know better, however, have lost this fear and are responsible of the failure to establish herd immunity, and of the occasional deaths of immunodepressed or just unlucky people due to preventable diseases.

Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @11:40PM (#16835735)
You seem to be responding to something I didn't say.

I only said that demand for any preventive measures against X, can be artificially inflated by injecting fear of X into the populace.

Since vaccines are a preventive measure, this is applicable to vaccines as well.

Re:Goldman Sachs questions whether curing patients is a sust... by masklinn on Friday April 13, 2018 @05:10AM (#16828219)
> There is another one. Vaccines.

Vaccines are absolute shit from a business perspective. They're expensive to develop, generally cheap to produce, and their administration is a single or limited event point. Sure you've got breadth but you've got no depth, once an individual is vaccinated they're done, or maybe they'll need an other round years from now.

Big pharma companies absolutely hate vaccines, having people pay for repeated treatment is way more business-beneficial.

And as other commenters have noted, herd immunity is a well-studied concept, and vaccines have very much proved their worth multiple times over.

Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @05:40AM (#16828366)
> administration is a single or limited event point.

What about flu vaccines? Even govt runs ads urging people to get their flu shots, even though they have been shown to be useless.

Re:Goldman Sachs questions whether curing patients is a sust... by kdelok on Friday April 13, 2018 @05:53AM (#16828424)
Flu vaccines aren't useless, but they also aren't 100% effective. The CDC reckoned they reduce the risk by about 40-60%.

Flu is a variable pathogen, which means that it evolves to look different from an immune perspective over time. It follows clustered patterns, where the flu strain will look pretty similar (and vaccines will be more effective), then it "jumps" to a new cluster every few years or so (and the vaccines will likely be less effective). There's a whole bunch of work goes into predicting what flu strains make most sense to use for the vaccine in a given flu season.

Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @05:57AM (#16828451)
> CDC reckoned they reduce the risk by about 40-60%.

curious, Do you have a link to this by any chance?

According to this

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693492/

After looking at "328 households with 1441 members, including 839 children," for an entire year (2011) these authors determined that there was a difference of 4/10ths of one percentage point between those who received flu vaccine and those who didn't.

The infection risk was 8.5% in the vaccinated and 8.9% in the unvaccinated.

According to this CDC study https://academic.oup.com/cid/article/64/5/544/2758477

"We observed decreasing vaccine effectiveness with increasing time. Maximum vaccine effectiveness was observed shortly after vaccination, followed by a decline..... Vaccine effectiveness remained greater than zero for at least six months for influenza A(H1N1) and influenza B and at least five months for influenza A(H3N2) viruses."

They say "greater than zero" , far cry from 40- 60% :D

Cannot post more replies atm, but for people saying 5% is still something.

> Going from 8.9% to 8.5% is a 5% reduction in flu cases. If this translates to 5% fewer sick days during the flu-period and a 5% reduction in doctor visits that are due to flu symptoms (some people go to the doctor for everything), that can absolutely be a reason for the government to want people to get their flu shots.

This line of reasoning assumes that there are only positive effects from vaccines. There are many many side effects of flu vaccines.

Just to quote one,

http://journals.plos.org/plosone/article?id=10.1371/journal....

"Hospitalizations were slightly more common among subjects who were vaccinated than among the others"

"hospitalizations for pneumonia and influenza, that were 47% more likely among subjects who received the tetravalent vaccine as compared with those who were not vaccinated."

Re:Goldman Sachs questions whether curing patients is a sust... by bonzini on Friday April 13, 2018 @06:18AM (#16828533)
That's a 0.4/8.9 reduction, about 5%. However, flu vaccine isn't useful to the general population. In many countries is usually administered to people that are most likely to develop complications such as pulmonitis.
Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @01:34PM (#16832114)
> However, flu vaccine isn't useful to the general population.

CDC makes no such distinctions in USA.

https://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.html

Any references to your claims?

Re:Goldman Sachs questions whether curing patients is a sust... by bonzini on Friday April 13, 2018 @02:41PM (#16832780)
Italian only, but see item 11 of http://www.salute.gov.it/portale/p5_1_2.jsp?id=103 - should be easy for Google to translate it.

Though I should have written "isn't _equally_ useful to everyone in the general population".

Re:Goldman Sachs questions whether curing patients is a sust... by moccachino on Friday April 13, 2018 @08:59AM (#16829533)
To quote your quote of my response:

----

> > Going from 8.9% to 8.5% is a 5% reduction in flu cases. If this translates to 5% fewer sick days during the flu-period and a 5% reduction in doctor visits that are due to flu symptoms (some people go to the doctor for everything), that can absolutely be a reason for the government to want people to get their flu shots.

> This line of reasoning assumes that there are only positive effects from vaccines. There are many many side effects of flu vaccines.

----

This is why I also said:

>So assuming that the flu vaccine is harmless and the cost is not too great, it can make sense to get it even if the effectiveness rate is low.

Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @10:17AM (#16830191)
oh sorry. missed that line from your response.
Re:Goldman Sachs questions whether curing patients is a sust... by PeterStuer on Friday April 13, 2018 @08:33AM (#16829344)
As far as I remember flu vaccines work by looking at the origins of the yearly epidemic (in the east, typically china etc.), predicting which strains will become the dominant ones and then starting to cultivate neutered forms of those (in eggs) on a mass scale to have the vaccines ready by the time the epidemic hits 'the west'. Some years the predictions of the strain are wrong and the vaccines less useful as most people will get another strain.
Re:Goldman Sachs questions whether curing patients is a sust... by kdelok on Friday April 13, 2018 @06:01PM (#16834265)
They do strain selection twice a year (once for northern, once for southern hemisphere). The years where they get it wrong are usually the years where the strain jumps between different clusters.

It's really interesting stuff. Take a look at https://www.whocc.infectiousdisease.cam.ac.uk/antigenic-cart... for a bit of an overview on that stuff.

Re:Goldman Sachs questions whether curing patients is a sust... by kdelok on Friday April 13, 2018 @04:55PM (#16833831)
Yeah, I didn't look particularly critically at it, but this is where I got the figure from: https://www.cdc.gov/flu/about/qa/vaccineeffect.htm
Re:Goldman Sachs questions whether curing patients is a sust... by bluGill on Friday April 13, 2018 @12:10PM (#16831333)
That is for 2011. The effectiveness of the vaccine is different every year. Some years it gets close to 80% (from memory and probably wrong), some years it is only 10%. The average across all years tends to be 40%.
Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @01:32PM (#16832098)
Do you have references to numbers your are quoting? I searched for 60-80% number quoted by GP but found nothing even close.
Re:Goldman Sachs questions whether curing patients is a sust... by bluGill on Friday April 13, 2018 @02:48PM (#16832841)
https://www.cdc.gov/flu/professionals/vaccination/effectiven...

Where my numbers disagree with the above (nearly all!) I stand corrected.

Re:Goldman Sachs questions whether curing patients is a sust... by moccachino on Friday April 13, 2018 @06:18AM (#16828536)
Going from 8.9% to 8.5% is a 5% reduction in flu cases. If this translates to 5% fewer sick days during the flu-period and a 5% reduction in doctor visits that are due to flu symptoms (some people go to the doctor for everything), that can absolutely be a reason for the government to want people to get their flu shots.

Personally I have never had a flu shot and am not inclined to start doing so, but I know people who have and according to them, if they do get the flu it affects them less in the years they get their shots vs. when they don't. So assuming that the flu vaccine is harmless and the cost is not too great, it can make sense to get it even if the effectiveness rate is low.

Re:Goldman Sachs questions whether curing patients is a sust... by megaman22 on Friday April 13, 2018 @08:12AM (#16829205)
I almost wonder, in my more cynical moments, if "flu shots" are people just paying to get poked with a couple of cc's of saline, for all the effectiveness it seems to provide.
Re:Goldman Sachs questions whether curing patients is a sust... by bluGill on Friday April 13, 2018 @12:11PM (#16831349)
Don't confuse the flu with the common cold as many people do. The flu vaccine does nothing for the common cold.

Even at their worst the flu vaccine makes the flu less deadly when you get it.

Re:Goldman Sachs questions whether curing patients is a sust... by collyw on Friday April 13, 2018 @06:58AM (#16828775)
Where have they been shown to be useless?
Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @10:19AM (#16830219)
Re:Goldman Sachs questions whether curing patients is a sust... by collyw on Saturday April 14, 2018 @08:01AM (#16836955)
I find the way that response has been worded to be misleading. Labeling an effectiveness of around 5% as 4/10ths of a percentage demonstrates a desire to mislead the reader.

Most people will shake off a flu infection easily. The elderly or people with other medical problem may not, so I find it a weak argument to say they are useless based on that study.

The second study quoted is pretty much what I would expect based on my knowledge of influenza virus. It evolves quickly, which is why being exposed to it once year doesn't build up your immunity to the evolved strain going around a year later

To say they are useless is just wrong.

Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @05:19AM (#16828258)
Vaccines provide, a nice, predictable, ever increasing demand. It is even possible to create arbitrary demand in the case of preventive measures such as these.

Profit from any normal drug is dependent on chance that a certain number of people will fall sick of the corresponding disease. The company cannot also count on outbreaks since it will have no clue when, where and for which disease the outbreak will occur. The expire date for drugs means that the companies will not be able to stockpile these drugs in hopes that there will be an outbreak some point in future..

Re:Goldman Sachs questions whether curing patients is a sust... by dmurray on Friday April 13, 2018 @05:00AM (#16828167)
Vaccines also only get administered once, or a small number of times, per patient. It's hard for them to be as profitable as a drug which is "take this 3 times a day with meals, for the rest of your life, or you die".
Re:Goldman Sachs questions whether curing patients is a sust... by pjc50 on Friday April 13, 2018 @05:48AM (#16828409)
Vaccines are one of medicine's great discoveries that free humanity. The only reason people aren't terrified of disease and think they can get away with lying about vaccination is that we've driven it into the corners.

Unpreventable diseases are quite capable of creating their own fear, like the AIDS epidemic.

Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @07:28AM (#16828936)
I am sorry, but what part of my comment are you responding to?
Re:Goldman Sachs questions whether curing patients is a sust... by PeterStuer on Friday April 13, 2018 @05:04AM (#16828188)
I don't agree. Herd immunization is a solid concept. Besides, AFAIK most vaccines do not just work short-term while increasing the likelihood of future vaccination need.
Re:Goldman Sachs questions whether curing patients is a sust... by collyw on Friday April 13, 2018 @06:58AM (#16828772)
Antivaccers here? I expected better, but I see you have been rightful down voted.
Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Friday April 13, 2018 @10:25AM (#16830265)
Do you get flu vaccine every year?
Re:Goldman Sachs questions whether curing patients is a sust... by collyw on Saturday April 14, 2018 @08:09AM (#16836983)
Strawman.

I get vaccines for serious diseases when visiting foreign countries. Yellow fever, hepatitis, tetanus amongst others. So far I have manged to avoid becoming autistic.

I am in good health so have no real reason to get a flu shot. (One year my work offered me one and I took it).

Re:Goldman Sachs questions whether curing patients is a sust... by dominotw on Saturday April 14, 2018 @11:33AM (#16837728)
> preventive medicines that does not actually require people to be sick.

> I am in good health so have no real reason to get a flu shot.

Aren't you saying the exact same thing that you called "antivaccer".

CDC doesn't recommed flu to people who are not * in good health* , its a population wide recommendation. You being in good health is not relevant to GP's point of recommending vaccines to people who are not sick( which you seem to agree with).

Re:Goldman Sachs questions whether curing patients is a sust... by buvanshak on Friday April 13, 2018 @07:31AM (#16828953)
Which part of my comment is "Anti-vaccine"?